FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

31351811000001105: Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 03-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    96335501000001118 Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    96335601000001119 Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Is a Alogliptin 12.5mg / Metformin 1g tablets 56 tablet false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Has AMP Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Has specific active ingredient Alogliptin benzoate false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Has specific active ingredient Metformin hydrochloride false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alogliptin false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Is a Actual medicinal product pack false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet Has basis of strength substance Alogliptin false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start